Donald E. Mager - Search Results

Year	Number of Results
2002	2
2003	8
2004	6
2005	5
2006	4
2007	6
2008	5
2009	9
2010	15
2011	10
2012	14
2013	12
2014	11
2015	11
2016	8
2017	9
2018	8
2019	10
2020	4
2021	7
2022	6
2023	7
2024	5

1

Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.

Ramakrishnan S, Cortes-Gomez E, Athans SR, Attwood KM, Rosario SR, Kim SJ, Mager DE, Isenhart EG, Hu Q, Wang J, Woloszynska A. Ramakrishnan S, et al. Among authors: mager de. Genome Med. 2024 Apr 2;16(1):52. doi: 10.1186/s13073-024-01323-6. Genome Med. 2024. PMID: 38566104 Free PMC article. Review.

2

Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting Enzyme.

Nguyen VA, Zhang L, Kagan L, Rowland M, Mager DE. Nguyen VA, et al. Among authors: mager de. J Pharm Sci. 2024 Jan;113(1):167-175. doi: 10.1016/j.xphs.2023.10.025. Epub 2023 Oct 21. J Pharm Sci. 2024. PMID: 37871777

3

Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models.

Wang J, Chen T, Ruszaj DM, Mager DE, Straubinger RM. Wang J, et al. Among authors: mager de. J Pharm Sci. 2024 Jan;113(1):72-84. doi: 10.1016/j.xphs.2023.10.019. Epub 2023 Oct 14. J Pharm Sci. 2024. PMID: 37844759

4

Contributions of William Jusko to Development of Pharmacokinetic and Pharmacodynamic Models and Methods.

Mager DE, Straubinger RM. Mager DE, et al. J Pharm Sci. 2024 Jan;113(1):2-10. doi: 10.1016/j.xphs.2023.09.019. Epub 2023 Sep 30. J Pharm Sci. 2024. PMID: 37778439 No abstract available.

5

Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Lin LH, Ghasemi M, Burke SM, Mavis CK, Nichols JR, Torka P, Mager DE, Hernandez-Ilizaliturri FJ, Goey AKL. Lin LH, et al. Among authors: mager de. Target Oncol. 2023 Sep;18(5):685-695. doi: 10.1007/s11523-023-00992-4. Epub 2023 Aug 26. Target Oncol. 2023. PMID: 37632592 Clinical Trial.

6

Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.

McCune JS, Armenian SH, Nakamura R, Shan H, Kanakry CG, Mielcarek M, Gao W, Mager DE. McCune JS, et al. Among authors: mager de. J Oncol Pharm Pract. 2024 Mar;30(2):322-331. doi: 10.1177/10781552231171607. Epub 2023 May 3. J Oncol Pharm Pract. 2024. PMID: 37134196

7

Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.

Li R, Craig M, D'Argenio DZ, Betts A, Mager DE, Maurer TS. Li R, et al. Among authors: mager de. Front Pharmacol. 2023 Apr 12;14:1184914. doi: 10.3389/fphar.2023.1184914. eCollection 2023. Front Pharmacol. 2023. PMID: 37124233 Free PMC article. No abstract available.

8

Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia.

Derippe T, Fouliard S, Marchiq I, Dupouy S, Almena-Carrasco M, Geronimi J, Declèves X, Chenel M, Mager DE. Derippe T, et al. Among authors: mager de. Cancer Res Commun. 2022 Nov 30;2(11):1532-1544. doi: 10.1158/2767-9764.CRC-22-0176. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970053 Free PMC article.

9

Comparison of sequential and joint nonlinear mixed effects modeling of tumor kinetics and survival following Durvalumab treatment in patients with metastatic urothelial carcinoma.

Chen T, Zheng Y, Roskos L, Mager DE. Chen T, et al. Among authors: mager de. J Pharmacokinet Pharmacodyn. 2023 Aug;50(4):251-265. doi: 10.1007/s10928-023-09848-w. Epub 2023 Mar 12. J Pharmacokinet Pharmacodyn. 2023. PMID: 36906878

10

Accelerating robust plausible virtual patient cohort generation by substituting ODE simulations with parameter space mapping.

Derippe T, Fouliard S, Declèves X, Mager DE. Derippe T, et al. Among authors: mager de. J Pharmacokinet Pharmacodyn. 2022 Dec;49(6):625-644. doi: 10.1007/s10928-022-09826-8. Epub 2022 Oct 31. J Pharmacokinet Pharmacodyn. 2022. PMID: 36316606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

148 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year